Correlates of insulin injection omission.

Diabetes Care
Mark PeyrotLuther B Travis

Abstract

The purpose of this study was to assess factors associated with patient frequency of intentionally skipping insulin injections. Data were obtained through an Internet survey of 502 U.S. adults self-identified as taking insulin by injection to treat type 1 or type 2 diabetes. Multiple regression analysis assessed independent associations of various demographic, disease, and injection-specific factors with insulin omission. Intentional insulin omission was reported by more than half of respondents; regular omission was reported by 20%. Significant independent risk factors for insulin omission were younger age, lower income and higher education, type 2 diabetes, not following a healthy diet, taking more daily injections, interference of injections with daily activities, and injection pain and embarrassment. Risk factors differed between type 1 and type 2 diabetic patients, with diet nonadherence more prominent in type 1 diabetes and age, education, income, pain, and embarrassment more prominent in type 2 diabetes. Whereas most patients did not report regular intentional omission of insulin injections, a substantial number did. Our findings suggest that it is important to identify patients who intentionally omit insulin and be awar...Continue Reading

References

Oct 7, 1997·Diabetes Care·A H PaesC J Soe-Agnie
Mar 31, 1999·Diabetes Care·M Peyrot, R R Rubin
Jun 7, 2000·Diabetes Care·E D MollemaH M van der Ploeg
Jun 11, 2004·Clinical Therapeutics·Roger T AndersonRajesh Balkrishnan
Mar 29, 2005·Diabetes Care·Richard R RubinUNKNOWN Diabetes Prevention Program Research Group
Apr 27, 2005·The American Journal of Medicine·Richard R Rubin
Oct 18, 2005·The American Journal of Medicine·Jaime Davidson
Aug 2, 2007·Diabetes Care·Mark Peyrot, Richard R Rubin
Dec 22, 2007·Health and Quality of Life Outcomes·Frank J SnoekFrans Pouwer
Apr 19, 2008·Journal of Health and Social Behavior·Bruce G LinkEmily Leckman Westin
Jul 19, 2008·Health Economics, Policy, and Law·Todd H WagnerJohn D Piette
Nov 27, 2008·Diabetes Care·Jeffrey S GonzalezSteven A Safren
Jun 27, 2009·Current Medical Research and Opinion·Mark PeyrotRuediger Landgraf
Nov 26, 2009·The Diabetes Educator·Richard R RubinLuther B Travis

❮ Previous
Next ❯

Citations

Dec 26, 2012·Current Diabetes Reports·Orit Pinhas-Hamiel, Yael Levy-Shraga
Jun 11, 2010·Diabetes Technology & Therapeutics·Carl V AscheSwetha Raparla
Dec 24, 2010·Diabetes Technology & Therapeutics·Mark Peyrot, Richard R Rubin
Apr 28, 2012·Diabetes Technology & Therapeutics·Ronnie Aronson
Jun 17, 2011·American Journal of Nephrology·Luca NeriUNKNOWN MigliorDialisi Study Group
Nov 14, 2012·Therapeutic Advances in Endocrinology and Metabolism·Ammar Wakil, Stephen L Atkin
Aug 21, 2013·Indian Journal of Endocrinology and Metabolism·Subhash K WangnooMala Dharmalingam
Oct 23, 2013·The Patient·Meryl BrodJens Harald Kongsø
Nov 12, 2013·Primary Care Diabetes·Kamlesh KhuntiGuy Rutten
May 16, 2014·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Sanjay Kalra
Apr 12, 2014·Primary Care Diabetes·Shadi FarsaeiMostafa Qorbani
Dec 8, 2010·Acta Diabetologica·María L Isidro, Segundo Jorge
Nov 17, 2015·Expert Opinion on Biological Therapy·Tracy L SetjiMark N Feinglos
Mar 22, 2012·Expert Opinion on Drug Delivery·Xiaohui GuoSøren Kruse Lilleøre
Mar 27, 2012·Expert Opinion on Biological Therapy·Ammar Wakil, Stephen L Atkin
Sep 14, 2012·Expert Opinion on Drug Delivery·Rosemarie LajaraJerome Thurman
Jan 22, 2013·Expert Opinion on Drug Delivery·Ligang Xue, Kristian Handberg Mikkelsen
Jul 26, 2011·Current Medical Research and Opinion·Stephen BruntonAnthony H Barnett
Aug 31, 2011·Current Medical Research and Opinion·Carsten M Kristensen, Søren K Lilleøre
Nov 16, 2012·Current Medical Research and Opinion·Meryl BrodAnthony H Barnett
Sep 29, 2011·Current Medical Research and Opinion·Stuart A RossJohn Ashkenas
Oct 11, 2011·Current Medical Research and Opinion·Mette BøgelundMorten Lammert
Mar 25, 2016·North American Journal of Medical Sciences·Satyajeet RoyJohn P Gaughan
Jan 8, 2015·Journal of Diabetes·Amy T LarkinZachary Bloomgarden
Dec 1, 2015·Journal of Controlled Release : Official Journal of the Controlled Release Society·Michael Clinton KoettingNicholas A Peppas
Oct 17, 2015·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Rosemarie LajaraCarla Nikkel
Jul 23, 2013·International Journal of Clinical Practice·A LieblUNKNOWN SOLVE Study Group
Mar 26, 2011·Pediatric Diabetes·Edith SchoberUNKNOWN Austrian Diabetic Incidence Study Group
May 18, 2012·Journal of the American Academy of Nurse Practitioners·Tom Bartol
Dec 14, 2011·Diabetic Medicine : a Journal of the British Diabetic Association·P D HomeK I Birkeland
Jan 18, 2013·Diabetic Medicine : a Journal of the British Diabetic Association·M J DaviesR Hughes

❮ Previous
Next ❯

Related Concepts

Related Feeds

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

American Diabetes Association Journals

Discover the latest diabetes research published by the journals from the American Diabetes Association.

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.